Detalhe da pesquisa
1.
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Rheumatol Int
; 44(1): 73-80, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060005
2.
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
Rheumatol Int
; 44(5): 805-817, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470502
3.
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Rheumatol Int
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609655
4.
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
Rheumatol Int
; 43(12): 2211-2220, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37712977
5.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Int J Rheum Dis
; 27(5): e15178, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742751
6.
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
Rheumatol Adv Pract
; 8(2): rkae028, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524696
7.
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Int J Rheum Dis
; 27(5): e15161, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720408
8.
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus.
J Clin Med
; 12(24)2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137611